US Stocks
/
Viridian Therapeutics, Inc. Share Price
Viridian Therapeutics, Inc. Share Price

Viridian Therapeutics, Inc. Share Price

NASDAQ: VRDN | Small Cap
$18.67
+$0.34 (1.83%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Viridian Therapeutics, Inc. Stock Performance

Open
$18.41
Prev. Close
$18.34
Circuit Range
N/A
Day Range
$18.21 - $18.72
Year Range
$13.18 - $34.25
Volume
1,12,955
Average Traded
$18.53

Viridian Therapeutics, Inc. Share Price Today

As of 11 October 2026, Viridian Therapeutics, Inc.'s share price is $18.67. The stock opened at $18.41, compared to its previous close of $18.34. During today's trading session, Viridian Therapeutics, Inc.'s share price traded between $18.21 and $18.72, with an average price of $18.47. Over the past 52 weeks, the stock has recorded a high of $34.25 and a low of $13.18. In terms of performance, Viridian Therapeutics, Inc.'s share price has risen by 38.76% over the last six months and is down 20.96% on a year-on-year basis.

Viridian Therapeutics, Inc. Share Price Chart

$18.21$18.72
L
Show Current Price
H

Viridian Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.58B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.95
Revenue (TTM)
$70.85B
Return On Equity (TTM)
-50.46%
Profit Margin
-397.93%
Debt to Equity
0.54
Quarterly Earnings Growth YoY
-300.50%

Viridian Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$70.57$0.13$0.14$0.28
Net Profit-$28.17-$101.07-$92.03-$112.82
Net Profit Margin-39.92%-77746.15%-65735.71%-40292.86%
Income ChangeN/A-258.79%8.94%-22.59%

Viridian Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$1.77$0.31$0.30$70.85
Net Profit-$87.04-$175.01-$208.56-$281.93
Net Profit Margin-4917.51%-56454.84%-69520.00%-397.93%
Income ChangeN/A-101.07%-19.17%-35.18%

About Viridian Therapeutics, Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. The company is developing two anti-IGF-1R product candidates, veligrotug for intravenous (IV) administration and elegrobart (formerly VRDN-003) for subcutaneous (SC) administration, to treat patients with TED. Our most advance program, veligrotug, is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of TED.

Viridian Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$20.45
$18.70
-9.25%
Sep 2026
$23.19
$20.61
-13.75%
Aug 2026
$18.68
$23.89
+26.20%
Jul 2026
$18.95
$18.93
+2.94%
Jun 2026
$17.54
$18.39
+4.34%
May 2026
$13.58
$17.63
+30.99%
Apr 2026
$19.72
$13.46
-31.16%
Mar 2026
$28.76
$19.55
-33.41%
Feb 2026
$33.23
$29.35
-11.07%
Jan 2026
$31.23
$33.01
+6.02%
Dec 2025
$31.91
$31.13
-2.57%
Nov 2025
$23.78
$31.95
+35.27%

VRDN Share Price FAQs

What is Viridian Therapeutics, Inc. share price today?

chevron-up
Viridian Therapeutics, Inc. share price today is $18.67 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Viridian Therapeutics, Inc. stock?

chevron-up
The 52 week high of Viridian Therapeutics, Inc. stock is $34.25, while the 52 week low is $13.18 as of 10 Oct '26.

What is VRDN's market capitalisation today?

chevron-up
VRDN market capitalisation is $1.58B as of October 11, 2026, at 2:07 am IST.

What is VRDN's net income for the last quarter?

chevron-up
VRDN's net income for the last quarter is -112.82B USD.

What is the 5 year returns of VRDN?

chevron-up
The 5 year returns of VRDN is 3.15% as on 10 Oct '26.

What is the high & low stock price of VRDN today?

chevron-up
VRDN stock price hit a high of $18.72 and low of $18.21 as of 10 Oct '26.

Can I buy VRDN shares in India?

chevron-up
Yes. You can buy VRDN in India by opening an international trading account.